cannabinoid: THC/CBD

Tetrahydrocannabinol (THC)-based and cannabidiol (CBD)-based products are increasing in popularity for the management of pain. Cannabis-based ...

Cannabinoids in hair and their prospective association with mental and physical health outcomes in adolescents.

Cannabis is one of the most widely used drugs in early adolescence, a crucial time for ...

Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.

Cannabinoids have potential efficacy as prophylaxis for chemotherapy-induced nausea and vomiting (CINV), but no recent meta-analysis ...

Efficacy of cannabidiol alone or in combination with Δ-9-tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence.

Substance use disorders (SUD) lead to a high burden of disease, yet treatment options are limited. ...

The Pharmacokinetics and Pharmacodynamics of a Hemp-Derived „Full-Spectrum“ Oral Cannabinoid Product with a 1:1 Ratio of Cannabidiol to Cannabidiolic Acid and Delta-9-Tetrahydrocannabinol to Delta-9-Tetrahydrocannabinolic Acid: A Double-Blind, Placebo-Controlled, Within-Subjects Human Laboratory Study.

To examine the acute pharmacokinetics (PK) and pharmacodynamics (PD) of a patented oral cannabinoid product containing ...

The appetite stimulating effect and safety of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in older patients with poor appetite: A triple-blinded, randomized, placebo-controlled, cross-over trial.

Anorexia of aging is prevalent and constitutes a significant factor in the onset of malnutrition with ...

Characterizing the Population of a Medical Cannabis Clinic in a Pediatric Hospital.

Medical cannabis (MC) is increasingly in use due to recent cultural and political changes. Other than ...

The differential effects of medicinal cannabis on mental health: A systematic review.

The use of medicinal cannabis to improve mental health is increasing globally, both in clinical settings ...

Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Oral Cannabidiol and Tetrahydrocannabinol for Essential Tremor.

Essential tremor (ET) is characterized by often disabling action tremors. No pharmacological agent has been developed ...

Cannabidiol and cognitive functions/inflammatory markers in Parkinson’s disease: A double-blind randomized controlled trial at Buriram Hospital (CBD-PD-BRH trial).